Related references
Note: Only part of the references are listed.The effects of high-intensity interval training and saffron aqueous extract supplementation on alterations of body weight and apoptotic indices in skeletal muscle of 4T1 breast cancer-bearing mice with cachexia
Fereshteh Ahmadabadi et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2020)
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor
Wang Kai et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
Cameron N. Johnstone et al.
DISEASE MODELS & MECHANISMS (2018)
Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis
Soo-Hyun Kim et al.
DISEASE MODELS & MECHANISMS (2018)
Natural Products for the Management and Prevention of Breast Cancer
Sarmistha Mitra et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
Meysam Yousefi et al.
CELLULAR ONCOLOGY (2018)
Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
Christiana Neophytou et al.
FRONTIERS IN ONCOLOGY (2018)
Emerging ways to treat breast cancer: will promises be met?
Pouria Samadi et al.
CELLULAR ONCOLOGY (2018)
10-Gingerol, a Phytochemical Derivative from Tongling White Ginger, Inhibits Cervical Cancer: Insights into the Molecular Mechanism and Inhibitory Targets
Fang Zhang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters
Mitra Tewes et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
[10]-Gingerol Reverts Malignant Phenotype of Breast Cancer Cells in 3D Culture
Angelina M. Fuzer et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
Clinton Yam et al.
ONCOLOGIST (2017)
[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo
Ana Carolina B. M. Martin et al.
ONCOTARGET (2017)
NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice
Madhavi Puchalapalli et al.
PLOS ONE (2016)
Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy
Shyamala Maheswaran et al.
CANCER RESEARCH (2015)
Gingerols and shogaols: Important nutraceutical principles from ginger
Ruchi Badoni Semwal et al.
PHYTOCHEMISTRY (2015)
[10]-Gingerol induces mitochondrial apoptosis through activation of MAPK pathway in HCT116 human colon cancer cells
Min Ju Ryu et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2015)
Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness
David L. Waning et al.
CLINICAL CANCER RESEARCH (2014)
[6]-gingerol as a Cancer Chemopreventive Agent: A Review of Its Activity on Different Steps of the Metastatic Process
Juliana Poltronieri et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2014)
An Evaluation of Hepatotoxicity in Breast Cancer Patients Receiving Injection Doxorubicin
G. Damodar et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2014)
Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma
Nuray Erin et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
In vivo animal models for studying brain metastasis: value and limitations
Inderjit Daphu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle
Laura A. A. Gilliam et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis
Nicole Kusuma et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Purification and differential biological effects of ginger-derived substances on normal and tumor cell lines
James Almada da Silva et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2010)
Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
Ana Bosch et al.
CANCER TREATMENT REVIEWS (2010)
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
Henk J. Broxterman et al.
DRUG RESISTANCE UPDATES (2009)
Imagable 4T1 model for the study of late stage breast cancer
Kai Tao et al.
BMC CANCER (2008)
The current state of serum biomarkers of hepatotoxicity
Josef Ozer et al.
TOXICOLOGY (2008)
Identification of the functional role of AF1Q in the progression of breast cancer
Xin-Zhong Chang et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Metastasis: recent discoveries and novel treatment strategies
Suzanne A. Eccles et al.
LANCET (2007)
Adriamycin-induced myocardial toxicity: New solutions for an old problem?
Delia Outomuro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin
KF Hofland et al.
CLINICAL CANCER RESEARCH (2005)
H2AX: the histone guardian of the genome
O Fernandez-Capetillo et al.
DNA REPAIR (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Doxorubicin and taxane combination regimens for metastatic breast cancer: Focus on cardiac effects
V Valero et al.
SEMINARS IN ONCOLOGY (2001)
Drug therapy - Side effects of adjuvant treatment of breast cancer
CL Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Abnormal findings on liver function tests - Interpreting results to narrow the diagnosis and establish a prognosis
DV Gopal et al.
POSTGRADUATE MEDICINE (2000)
Share Paper
